查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1992386

注射用水生產系統市場：按類型、系統組件、技術類型、系統配置和最終用戶分類－2026-2032年全球預測

Water for Injection Production System Market by Type, System Components, Technology Type, System Configuration, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，注射用水生產系統市場價值將達到 35.8 億美元，到 2026 年將成長至 37.2 億美元，到 2032 年將達到 52.4 億美元，複合年成長率為 5.58%。

主要市場統計數據
基準年 2025 35.8億美元
預計年份：2026年 37.2億美元
預測年份 2032 52.4億美元
複合年成長率 (%) 5.58%

為注射用水生產系統制定優先策略框架，將監管要求、業務永續營運和臨床及商業生產中的資本規劃連結起來。

本執行摘要概述了注射用水 (WFI) 生產系統的戰略背景，並重點關注影響生命科學和醫療保健領域投資決策的關鍵營運、監管和技術優先事項。生產藥用級注射用水需要融合嚴謹的工程設計、檢驗的製程控制和持續的風險管理，以維持注射給藥所需的無菌性和內毒素控制。隨著設施的現代化，相關人員要求系統能夠兼顧可靠的微生物控制、節能運作和可預測的生命週期維護。

技術創新、更嚴格的法規和永續性要求如何重塑WFI製造供應商的價值提案和設施投資選擇。

在技​​術進步、監管力度加大以及對永續性重視的推動下，注射用水（WFI）生產系統正經歷著變革性的轉變。膜技術的進步和新型熱濃縮策略正在改變設計中的權衡取捨，從而在保持微生物控制的同時，提高回收率並降低能耗。同時，數位化引入了預測性維護和持續監控功能，提高了運轉率和驗證可追溯性，進而重塑了採購標準和服務模式。

評估 2025 年美國關稅變化對 WFI 設備供應鏈重組、供應商多元化和籌資策略。

2025年美國關稅政策的變化為全球供應鏈中的供應商和買家帶來了新的成本考量。關稅影響了進口設備和零件的經濟效益，促使製造商重新評估籌資策略並評估其供應商網路的韌性。為此，採購團隊擴大了供應商選擇範圍，包括尋找國內替代方案，並檢驗能夠降低關稅風險的製造結構。這種調整改變了前置作業時間的預期，並影響了有關零件標準化、備件庫存管理和本地組裝方案的決策。

將系統類型、組件優先順序和最終用戶採購因素連結起來的詳細細分分析，可以製定有針對性的產品和服務策略。

關鍵的細分市場洞察揭示了技術規格、系統結構和最終用戶需求如何驅動WFI生態系統中多樣化的採購和整合策略。按類型分類，市場涵蓋薄膜技術、多級蒸餾、逆滲透系統和蒸氣壓縮，這些差異體現在生命週期成本、能耗特徵和驗證方法上。依賴薄膜技術的系統通常優先考慮緊湊的面積和模組化設計，而當熱穩定性和高純度要求決定製程選擇時，則需要多級蒸餾解決方案。

區域趨勢和當地監管實踐正在影響美洲、歐洲、中東和非洲以及亞太地區的部署模式、供應商策略和服務模式。

區域分析突顯了法律規範、基礎設施成熟度和醫療服務模式如何影響不同地區的技術採納和服務預期。在美洲，對監管一致性的高度重視以及嚴格的驗證要求，加上競爭激烈的供應商環境，推動了數位化監控和自動化在流程控制領域的快速應用。相較之下，歐洲、中東和非洲（EMEA）的需求則更為多樣化，既有成熟的管理體制，也有優先考慮成本效益和在地化服務網路的新興市場。這就要求供應商提供模組化、擴充性的解決方案和本地化的支援模式。

領先供應商如何透過結合檢驗的工程技術、服務生態系統和模組化解決方案來脫穎而出，從而確保長期夥伴關係和持續的業務收益。

企業層面的關鍵洞察凸顯了領先供應商如何透過結合技術優勢、卓越服務和夥伴關係模式來降低終端用戶計劃的複雜性，從而實現差異化競爭。頂級供應商透過將產品設計與強大的試運行和合格支援相結合，並提供可追溯的驗證交付物和培訓，加速了設施推出。許多製造商也在擴展售後服務，引入預測性維護計劃和遠端監控，以提高運作和延長設備使用壽命。這正在創建一個永續的收入模式，使客戶績效與獎勵緊密相關。

採購、工程和品質負責人可以採取切實可行的、高優先級的行動，以降低檢驗風險、提高運作和增強供應鏈韌性。

針對行業領導者的實用建議著重於協調技術、監管和商業性策略，以確保業務永續營運和競爭優勢。首先，透過優先考慮降低驗證複雜性並融入支援持續監控和快速診斷功能的設計，縮短調查週期。其次，修訂籌資策略，對關鍵零件採用雙重採購和近岸外包，以降低貿易和關稅風險，同時確保合約中關於前置作業時間和備件供應的清晰度。

我們採用透明且可重複的研究途徑，結合專家訪談、監管審查和技術整合，得出可操作且檢驗的產業見解。

本調查方法以對技術專家和從業人員的定性研究為基礎，並輔以對監管指南、技術標準和公開技術文獻的嚴格審查。主要工作流程包括對製程工程師、品質保證經理和設施計劃經理進行結構化訪談，以收集關於系統選擇標準、驗證挑戰以及整個生命週期服務預期的第一手觀點。這些訪談內容被整合起來，以識別反覆出現的主題、風險點和基於最佳實踐的風險緩解策略，並將這些內容納入產品設計建議和採購清單中。

最終的綜合分析重點強調了彈性系統設計、強大的供應商夥伴關係和前瞻性的生命週期策略——所有這些對於確保無菌生產的性能至關重要。

總之，注射用水生產系統仍是無菌產品製造中至關重要且需要精細控制的環節。近期技術、法規和貿易的發展進一步凸顯了彈性設計、經驗證的控制結構以及供應商透明度的重要性。相關人員必須平衡污染控制、運轉率和能源效率等營運需求與供應鏈穩健性和檢查準備等策略需求。成功的供應商將是那些能夠提供整合解決方案的供應商，這些解決方案將成熟的技術性能與全生命週期服務相結合，從而簡化合格並保持運作可靠性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：注射用水生產系統市場：依類型分類

  • 膜技術
  • 多級蒸餾
  • 逆滲透系統
  • 蒸氣壓縮

第9章 注射用水生產系統市場：依系統組件分類

  • 過濾裝置
  • 泵浦
  • 儲存槽

第10章：注射用水生產系統市場：依技術類型分類

  • 蒸髮型
  • 過濾類型

第11章 依系統配置分類的注射用水生產系統市場

  • 獨立版
  • 融合的

第12章 注射用水生產系統市場：依最終用戶分類

  • 生技公司
  • 合約研究機構
  • 醫院和醫療機構
  • 製藥

第13章 注射用水生產系統市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 注射用水生產系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 注射用水生產系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國注射用水生產系統市場

第17章：中國注射用水生產系統市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aqua-Chem, Inc.
  • Asahi Kasei Corporation
  • BWT Holding GmbH
  • Donaldson Company, Inc.
  • Evoqua Water Technologies LLC
  • GE HealthCare Technologies Inc.
  • GEA Group
  • H2O GmbH
  • IDEX Corporation
  • MECO Incorporated
  • Merck KGaA
  • Pall Corporation by Danaher Corp.
  • Paul Mueller Company
  • Pentair plc
  • Sartorius AG
  • SPX Flow, Inc.
  • STERIS plc.
  • Stilmas SPA
  • SUEZ Water Technologies & Solutions
  • Sulzer Ltd.
  • Suncombe Limited.
  • Syntegon Technology GmbH
  • Thermo Fisher Scientific Inc.
  • Veolia Water Technologies
  • Xylem Inc.
Product Code: MRR-3204321AF10B

The Water for Injection Production System Market was valued at USD 3.58 billion in 2025 and is projected to grow to USD 3.72 billion in 2026, with a CAGR of 5.58%, reaching USD 5.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.58 billion
Estimated Year [2026] USD 3.72 billion
Forecast Year [2032] USD 5.24 billion
CAGR (%) 5.58%

A strategic framing of Water for Injection system priorities that links regulatory expectations, operational resilience, and capital planning across clinical and commercial manufacturing

This executive summary introduces the strategic context for Water for Injection production systems and frames the primary operational, regulatory, and technological priorities shaping investment decisions across life sciences and healthcare sectors. The production of pharmaceutical-grade water demands a confluence of engineering rigor, validated process controls, and ongoing risk management to maintain sterility and endotoxin control for parenteral applications. As facilities modernize, stakeholders seek systems that combine reliable microbiological control, energy-efficient operation, and predictable lifecycle maintenance.

The introduction emphasizes how capital project design interacts with quality frameworks, including system validation, change control, and Ongoing Product Quality Monitoring. It further highlights how procurement teams weigh total cost of ownership against operational resilience, driven by regulatory inspections and the imperative to minimize contamination risk. By connecting these operational priorities to the broader strategic aims of manufacturing continuity and patient safety, this section sets the stage for deeper analysis that follows. Transitional commentary prepares readers to move from framing to an assessment of shifting drivers and the implications for vendors, OEMs, and end users.

How technological innovation, regulatory intensification, and sustainability imperatives are reshaping supplier value propositions and facility investment choices in WFI production

The landscape for Water for Injection production systems is undergoing transformative shifts driven by technological advancement, tightening regulatory attention, and a growing emphasis on sustainability. Advances in membrane technologies and newer thermal concentration strategies are changing design trade-offs, enabling higher recovery and lower energy use while maintaining microbiological control. Concurrently, digitalization has introduced predictive maintenance capabilities and continuous monitoring that improve uptime and validation traceability, thereby reshaping procurement criteria and service models.

Regulatory agencies have heightened scrutiny of water systems as an integral part of sterile manufacturing, prompting more rigorous approaches to risk assessments, qualification protocols, and event investigation. These changes push manufacturers and their suppliers to adopt design-for-sterility principles and robust contamination control strategies. Moreover, a visible drive toward resource efficiency is prompting developers to prioritize solutions with lower water and energy footprints and improved scalability. Taken together, these shifts are altering supplier value propositions and changing how end users evaluate capital projects, making long-term operability and compliance readiness as critical as initial purchase cost.

Assessment of how the 2025 changes to United States tariffs prompted supply chain reconfiguration, sourcing diversification, and procurement strategy adjustments for WFI equipment

United States tariff policy changes in 2025 introduced new cost considerations for vendors and buyers operating within global supply chains. The tariffs affected the economics of imported equipment and components, prompting manufacturers to reassess sourcing strategies and to evaluate the resilience of their supplier networks. In response, procurement teams expanded supplier qualification activities to include domestic alternatives and to validate manufacturing that reduces exposure to tariff risk. This recalibration altered lead time assumptions and influenced decisions around component standardization, spares stocking, and local assembly options.

Beyond direct cost impacts, tariff-driven shifts triggered strategic responses from original equipment manufacturers and system integrators who adapted by localizing certain manufacturing steps or by redesigning systems to reduce dependency on tariff-exposed components. The result is a heightened focus on supply chain transparency, more rigorous contractual protections, and a rebalancing of total cost of ownership models to better reflect geopolitical and trade uncertainties. For organizations planning upgrades or new installations, the tariffs underscored the importance of scenario planning and of maintaining flexibility to pivot sourcing and service arrangements as trade environments evolve.

In-depth segmentation analysis linking system types, component priorities, and distinct end-user procurement drivers to inform targeted product and service strategies

Key segmentation insights reveal how technical specifications, system architecture, and end-user requirements drive divergent procurement and integration strategies across the WFI ecosystem. Based on Type, market is studied across Membrane Technology, Multiple Effect distillation, Reverse Osmosis system, and Vapor Compression, and these distinctions inform lifecycle costs, energy profiles, and validation approaches. Systems that rely on membrane technology typically emphasize compact footprint and modularity, whereas multiple effect distillation solutions are sought where thermal robustness and high-purity demands dictate process choice.

Based on System Components, market is studied across Filtration Units, Pumps, and Storage Tanks, and the performance and maintainability of these components determine microbial control outcomes and operational continuity. Filtration unit design impacts particle and bioburden management, pump reliability governs flow stability and redosing risks, and storage tank configuration affects stagnation control and cleaning regimes. Based on End User, market is studied across Biotech Companies, Contract Research Organizations, Hospitals & Healthcare Institutions, and Pharmaceutical, and each end user segment brings distinct procurement drivers. Biotech organizations often prioritize speed to clinic and modular scalability, CROs value flexible, mobile-capable systems, hospitals emphasize reliability and simplified maintenance for clinical settings, and large pharmaceutical companies require proven vendor track records and integrated qualification support. These segmentation lenses collectively guide vendors in tailoring technical roadmaps, service offerings, and commissioning packages to the specific needs of each buyer class.

Regional dynamics and localized regulatory practices that shape adoption patterns, vendor strategies, and service models across the Americas, EMEA, and Asia-Pacific

Regional insights highlight how regulatory frameworks, infrastructure maturity, and healthcare delivery models shape technology adoption and service expectations across broad geographies. Americas show a strong emphasis on regulatory alignment with advanced validation expectations and a competitive supplier landscape that drives rapid adoption of digital monitoring and automation for process control. In contrast, Europe, Middle East & Africa present a heterogeneous set of requirements where established regulatory regimes coexist with emerging markets that prioritize cost-effectiveness and localized service networks, prompting vendors to offer modular, scalable solutions and regional support models.

Asia-Pacific displays a diverse mix of high-capacity manufacturing hubs combined with rapidly expanding clinical infrastructure, creating demand for both large-scale thermal solutions and compact membrane-based systems for new facilities. Across these regions, sustainability and water-efficiency considerations are increasingly prominent, and local regulatory interpretations of pharmacopeial standards influence validation strategies and installation timelines. Consequently, vendors and integrators must calibrate their commercial models and support capabilities to align with region-specific procurement cycles, qualification expectations, and life-cycle service demands.

How leading vendors differentiate by combining validated engineering, service ecosystems, and modular solutions to secure long-term partnerships and recurring service revenues

Key company-level insights emphasize how leading suppliers differentiate through a combination of technology leadership, service excellence, and partnership models that reduce project complexity for end users. Top-tier vendors integrate product design with robust commissioning and qualification support, providing traceable validation artifacts and training that accelerate facility start-up. Many manufacturers are also expanding aftermarket services to include predictive maintenance programs and remote monitoring that improve uptime and extend equipment life while creating recurring revenue models that align incentives with customer performance.

Strategic collaborations have become more common as equipment providers partner with systems integrators, controls specialists, and component manufacturers to deliver turnkey solutions that simplify bidder selection and reduce interface risk. In parallel, some companies invest in modular product lines that support phased facility builds and easier scalability. The competitive landscape rewards firms that demonstrate consistent regulatory inspection readiness, strong service networks, and the ability to deliver lifecycle cost reductions through energy-efficient designs and simplified validation paths. These differentiators determine which suppliers win long-term contracts and secure strategic partnerships with high-value end users.

Practical and prioritized actions that procurement, engineering, and quality leaders can implement to reduce validation risk, improve uptime, and enhance supply chain resilience

Actionable recommendations for industry leaders focus on aligning technical, regulatory, and commercial strategies to secure operational continuity and competitive advantage. First, prioritize designs that reduce validation complexity and incorporate features that support continuous monitoring and rapid diagnostics to shorten investigation cycles. Second, reassess sourcing strategies to include dual-sourcing or nearshoring for critical components to mitigate trade and tariff exposure while maintaining contractual clarity on lead times and spare parts availability.

Third, invest in service models that combine remote monitoring with predictive analytics to move from reactive maintenance to condition-based interventions, thereby improving uptime and lowering lifecycle costs. Fourth, engage early with regulatory and quality teams during system selection to ensure that design choices support qualification plans and inspection readiness. Finally, foster cross-functional vendor partnerships that align product roadmaps with end-user needs for modularity, energy efficiency, and lifecycle support. By implementing these measures, organizations can reduce risk, accelerate commissioning, and capture greater operational predictability from their Water for Injection investments.

A transparent and reproducible research approach combining expert interviews, regulatory review, and technical synthesis to produce actionable and verifiable industry insights

The research methodology combines primary qualitative engagement with technical experts and practitioners, supplemented by a rigorous review of regulatory guidance, engineering standards, and publicly available technical literature. Primary workstreams included structured interviews with process engineers, quality assurance leads, and facility project managers to capture firsthand perspectives on system selection criteria, validation challenges, and lifecycle service expectations. These interviews were synthesized to identify recurring themes, risk points, and best-practice mitigations that inform both product design recommendations and procurement checklists.

Secondary analysis encompassed a review of regulatory guidance documents, pharmacopeial monographs, technical whitepapers, and vendor technical specifications to validate technical claims and to map technological trends against compliance requirements. Data triangulation ensured that insights reflected consistent patterns across multiple inputs and that recommendations addressed practical constraints observed in active projects. Throughout the methodology, emphasis was placed on transparency of assumptions, reproducibility of analytical steps, and the use of validated frameworks for supplier evaluation and risk assessment, enabling end users to adapt the approach to their internal governance processes.

Final synthesis highlighting the imperative for resilient system design, robust supplier partnerships, and proactive lifecycle strategies to secure sterile manufacturing performance

In conclusion, Water for Injection production systems remain a critical and sensitive element of sterile product manufacturing, and recent technological, regulatory, and trade developments have increased the importance of resilient design, validated controls, and supplier transparency. Stakeholders must balance operational imperatives-such as contamination control, uptime, and energy efficiency-with strategic requirements for supply chain robustness and inspection readiness. Vendors that succeed will be those that offer integrated solutions coupling proven technical performance with lifecycle services that simplify qualification and sustain operational reliability.

Looking ahead, organizations that proactively adopt modular designs, invest in monitoring and predictive maintenance, and align procurement strategies with risk mitigation principles will be best positioned to manage evolving compliance and commercial pressures. The synthesis presented here guides decision-makers toward pragmatic investments and partnership approaches that prioritize patient safety, facility resilience, and predictable operational outcomes. Accordingly, the insights set the groundwork for deeper analysis and tailored engagements to support specific program-level decisions and capital projects.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Water for Injection Production System Market, by Type

  • 8.1. Membrane Technology
  • 8.2. Multiple Effect distillation
  • 8.3. Reverse Osmosis system
  • 8.4. Vapor Compression

9. Water for Injection Production System Market, by System Components

  • 9.1. Filtration Units
  • 9.2. Pumps
  • 9.3. Storage Tanks

10. Water for Injection Production System Market, by Technology Type

  • 10.1. Evaporation-Based
  • 10.2. Filtration-Based

11. Water for Injection Production System Market, by System Configuration

  • 11.1. Standalone
  • 11.2. Integrated

12. Water for Injection Production System Market, by End User

  • 12.1. Biotech Companies
  • 12.2. Contract Research Organizations
  • 12.3. Hospitals & Healthcare Institutions
  • 12.4. Pharmaceutical

13. Water for Injection Production System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Water for Injection Production System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Water for Injection Production System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Water for Injection Production System Market

17. China Water for Injection Production System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Aqua-Chem, Inc.
  • 18.6. Asahi Kasei Corporation
  • 18.7. BWT Holding GmbH
  • 18.8. Donaldson Company, Inc.
  • 18.9. Evoqua Water Technologies LLC
  • 18.10. GE HealthCare Technologies Inc.
  • 18.11. GEA Group
  • 18.12. H2O GmbH
  • 18.13. IDEX Corporation
  • 18.14. MECO Incorporated
  • 18.15. Merck KGaA
  • 18.16. Pall Corporation by Danaher Corp.
  • 18.17. Paul Mueller Company
  • 18.18. Pentair plc
  • 18.19. Sartorius AG
  • 18.20. SPX Flow, Inc.
  • 18.21. STERIS plc.
  • 18.22. Stilmas S.P.A.
  • 18.23. SUEZ Water Technologies & Solutions
  • 18.24. Sulzer Ltd.
  • 18.25. Suncombe Limited.
  • 18.26. Syntegon Technology GmbH
  • 18.27. Thermo Fisher Scientific Inc.
  • 18.28. Veolia Water Technologies
  • 18.29. Xylem Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MULTIPLE EFFECT DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MULTIPLE EFFECT DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MULTIPLE EFFECT DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY REVERSE OSMOSIS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY REVERSE OSMOSIS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY REVERSE OSMOSIS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY VAPOR COMPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY VAPOR COMPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY VAPOR COMPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STORAGE TANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STORAGE TANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STORAGE TANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY EVAPORATION-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY EVAPORATION-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY EVAPORATION-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY HOSPITALS & HEALTHCARE INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY HOSPITALS & HEALTHCARE INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY HOSPITALS & HEALTHCARE INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 111. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 113. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 129. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 131. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 135. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 137. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)